Skip to main content
. 2022 Aug 12;22:39. doi: 10.1186/s40644-022-00476-0

Fig. 3.

Fig. 3

Investigator-assessed PFS by clinical variables in (A) the training (N = 846) and (B) the hold-out set (N = 422), and (C) the model incorporating imaging metrics in the training and (D) the hold-out set. CI, confidence interval; HR, hazard ratio; PFS, progression-free survival